Drugs used for cancer-associated anemia linked with increased risk of blood clots, death

Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news123315829.html">Drugs used for cancer-associated anemia linked with increased risk of blood clots, death</a></p> <p>Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.</p>